Evidence map›Paper›PMID 41971917›Full record

ArticleAME case reports2026

Hypertrophic cardiomyopathy associate with a

Xuezhen Chen, Sha Fu, Jieming Zhang, Yong Li

Abstract readCase Reports
In one paragraph

Article in AME case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xuezhen Chen *Department of Pediatric, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Sha Fu *Department of Cellular and Molecular Diagnostic Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Jieming ZhangDepartment of Cellular and Molecular Diagnostic Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Yong LiDepartment of Radiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hypertrophic cardiomyopathy (HCM) is a common hereditary disease of the myocardium, caused by mutations in at least 20 genes, encoding cardiac sarcomere proteins and sarcomere-associated proteins, while genes related to calcium metabolism, such as phospholamban ( Case Description: A 13-year-old male patient was admitted to the hospital due to "skin pallor", and was diagnosed with mild thalassemia by cytopenia and loss of heterozygosity of thalassemia gene α3.7. The symptoms were improved after iron supplementation. During hospitalization, the child complained of precordial pain. Echocardiogram and cardiac magnetic resonance (CMR) were performed, which showed thickening of the anterior septal basal segment, with the maximum thickness of 14 mm and a Z-score of 5.6 (Boston standard), and left ventricular outflow tract obstruction (dynamic). The subject carried a missense mutation of Conclusions: This case highlights HCM caused by

Indexed as

cardiac magnetic resonance (CMR)case reportechocardiogramHypertrophic cardiomyopathy (HCM)phospholamban gene mutations (PLN gene mutations)

Identifiers

PMID41971917
PMCPMC13062828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.